FDA data Registry peer set 3 peers

Alternatives to valganciclovir

3 same-class SPL records vs valganciclovir - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Valcyte

Antiviral (Nucleoside Analog) Prescription 3 alternatives found

About valganciclovir

Valganciclovir is an antiviral medicine. It helps prevent cytomegalovirus (CMV) disease in children who have received kidney or heart transplants.

Used for: This medicine prevents CMV disease in children after they get a kidney or heart transplant. CMV is a virus that can cause problems in people with weakened immune systems. Valganciclovir helps to stop the virus from growing and causing illness.

3 Antiviral (Nucleoside Analog) peers (wide set)

Compare valganciclovir vs acyclovir side-by-side →

valganciclovir vs acyclovir & famciclovir · FAERS reaction fields

FAERS top-reaction field "Diarrhoea" shows the widest count spread between valganciclovir and acyclovir, famciclovir, ganciclovir in this extract (6,148-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect valganciclovir acyclovirfamciclovirganciclovir
Cytomegalovirus Infection 1,756 - - 1,170
Neutropenia 1,096 3,074 - 503
Pyrexia 939 4,719 87 590
Diarrhoea 916 7,064 179 434
Leukopenia 914 - - 331
Acute Kidney Injury 797 - - 305
Death 754 4,676 86 -
Cytomegalovirus Viraemia 722 - - 413

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

valganciclovir peer mix vs class inventory

Peer mix

0 OTC and 3 Rx SPL records in this peer set (3 total). Class inventory for Antiviral (Nucleoside Analog): 4 drugs.

Frequently Asked Questions

What same-class SPL records sit beside valganciclovir?
This registry lists 3 Antiviral (Nucleoside Analog) medication records beside valganciclovir, including acyclovir, famciclovir, ganciclovir. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Antiviral (Nucleoside Analog) peer set (3 records)

valganciclovir (Valcyte) sits in a wide Antiviral (Nucleoside Analog) peer set (3 of 3 class peers shown). Labeled indication field for valganciclovir: This medicine prevents CMV disease in children after they get a kidney or heart transplant.

Top FAERS reaction fields for valganciclovir total 9,193 reports across 10 reactions, set beside acyclovir, famciclovir, ganciclovir. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full valganciclovir profile →

Field note for valganciclovir: see also the generic vs brand label guide when reading Valcyte SPL strings.